ATE218871T1 - Verwendung eines inositoltriphosphatesters zur behandlung von entzündungen - Google Patents

Verwendung eines inositoltriphosphatesters zur behandlung von entzündungen

Info

Publication number: ATE218871T1
Authority: AT; Austria
Prior art keywords: pct; damage; tissue damage; sec; inflammatory conditions
Prior art date: 1993-11-22

Application number

AT95901676T

Other languages

English (en)

Inventor

Lars Persson

Nicola Rehnberg

Torgny Gustafsson

Original Assignee

Perstorp Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-11-22

Filing date

1994-11-18

Publication date

2002-06-15

1994-11-18 Application filed by Perstorp Ab filed Critical Perstorp Ab

2002-06-15 Application granted granted Critical

2002-06-15 Publication of ATE218871T1 publication Critical patent/ATE218871T1/de

Links

206010061218 Inflammation Diseases 0.000 title 1
230000004054 inflammatory process Effects 0.000 title 1
CDAISMWEOUEBRE-UHFFFAOYSA-N inositol Chemical compound OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 title 1
235000011178 triphosphate Nutrition 0.000 title 1
239000001226 triphosphate Substances 0.000 title 1
230000006378 damage Effects 0.000 abstract 4
230000000451 tissue damage Effects 0.000 abstract 3
231100000827 tissue damage Toxicity 0.000 abstract 3
201000010099 disease Diseases 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
230000004968 inflammatory condition Effects 0.000 abstract 2
MMWCIQZXVOZEGG-UHFFFAOYSA-N 1,4,5-IP3 Natural products OC1C(O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(O)C1OP(O)(O)=O MMWCIQZXVOZEGG-UHFFFAOYSA-N 0.000 abstract 1
102000004506 Blood Proteins Human genes 0.000 abstract 1
108010017384 Blood Proteins Proteins 0.000 abstract 1
MMWCIQZXVOZEGG-XJTPDSDZSA-N D-myo-Inositol 1,4,5-trisphosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](O)[C@@H]1OP(O)(O)=O MMWCIQZXVOZEGG-XJTPDSDZSA-N 0.000 abstract 1
206010015866 Extravasation Diseases 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
206010030113 Oedema Diseases 0.000 abstract 1
208000027418 Wounds and injury Diseases 0.000 abstract 1
230000001154 acute effect Effects 0.000 abstract 1
230000002776 aggregation Effects 0.000 abstract 1
238000004220 aggregation Methods 0.000 abstract 1
210000002565 arteriole Anatomy 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
230000017531 blood circulation Effects 0.000 abstract 1
210000001736 capillary Anatomy 0.000 abstract 1
230000001684 chronic effect Effects 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
230000036251 extravasation Effects 0.000 abstract 1
239000012530 fluid Substances 0.000 abstract 1
208000014674 injury Diseases 0.000 abstract 1
210000000056 organ Anatomy 0.000 abstract 1
230000035699 permeability Effects 0.000 abstract 1
230000008961 swelling Effects 0.000 abstract 1
230000002792 vascular Effects 0.000 abstract 1
210000000264 venule Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

AT95901676T 1993-11-22 1994-11-18 Verwendung eines inositoltriphosphatesters zur behandlung von entzündungen ATE218871T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9303854A SE503122C2 (sv)	1993-11-22	1993-11-22	Användning av en inositoltrisfosfatester för behandling av inflammatoriska tillstånd
PCT/SE1994/001095 WO1995014477A1 (en)	1993-11-22	1994-11-18	The use of an ester of inositoltrisphosphate for the treatment of inflammatory conditions

Publications (1)

Publication Number	Publication Date
ATE218871T1 true ATE218871T1 (de)	2002-06-15

Family

ID=20391829

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95901676T ATE218871T1 (de)	1993-11-22	1994-11-18	Verwendung eines inositoltriphosphatesters zur behandlung von entzündungen

Country Status (10)

Country	Link
US (1)	US5866557A (de)
EP (1)	EP0730460B1 (de)
JP (1)	JP4172045B2 (de)
AT (1)	ATE218871T1 (de)
AU (1)	AU1081795A (de)
DE (1)	DE69430813T2 (de)
DK (1)	DK0730460T3 (de)
ES (1)	ES2177620T3 (de)
SE (1)	SE503122C2 (de)
WO (1)	WO1995014477A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9600194D0 (sv) *	1996-01-19	1996-01-19	Perstorp Ab	A new chemical compound
ES2383673T3 (es) *	2000-09-22	2012-06-25	Jpi Commercial, Llc	Composiciones de gamma-hidroxibutirato que contienen portadores de hidrato de carbonos
JP2004518639A (ja)	2000-11-21	2004-06-24	イノロジック，インコーポレイテッド	塩化物分泌を増加しそして炎症を阻害するためのイノシトール誘導体
FR2828206B1 (fr) *	2001-08-03	2004-09-24	Centre Nat Rech Scient	Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire
CA2488230C (en) *	2002-04-29	2013-04-09	Yves Claude Nicolau	Inositol pyrophosphates, and methods of use thereof
FI20021570A0 (fi) *	2002-09-03	2002-09-03	Gallen Kallela Siren Janne	Päällystetyn kirurgisen stentin paranneltu rakenne
EP2039683B1 (de) *	2002-10-03	2012-12-19	Targegen, Inc.	Vasculo-statisches Mittel und Anwendungsverfahren dafür
US20050250694A1 (en) *	2003-10-10	2005-11-10	Ma Jian-Xing	Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
US20050130897A1 (en) *	2003-12-11	2005-06-16	Ma Jian-Xing	Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
US7745423B2 (en) *	2004-07-06	2010-06-29	NormOxys, Inc	Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
US20060258626A1 (en) *	2004-07-06	2006-11-16	Claude Nicolau	Use of inositol-tripyrophosphate in treating tumors and diseases
US20060106000A1 (en) *	2004-07-06	2006-05-18	Claude Nicolau	Use of inositol-tripyrophosphate in treating tumors and diseases
JP5028405B2 (ja) *	2005-03-18	2012-09-19	ノームオクシスインコーポレイテッド	ヘモグロビンのアロステリックエフェクターとしてのミオイノシトール１，６：２，３：４，５トリピロリン酸のカルシウム塩
CA2674048A1 (en) *	2006-12-29	2008-07-10	Normoxys, Inc.	Cyclitols and their derivatives and their therapeutic applications
CA2688233A1 (en) *	2007-05-01	2008-11-06	Normoxys, Inc.	Erythropoietin complementation or replacement
US20080287341A1 (en) *	2007-05-18	2008-11-20	Danyang Chen	Treatment of vascular abnormalities using nanoparticles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4515722A (en) *	1982-03-30	1985-05-07	Merck & Co., Inc.	Phosphatidyl inositol analogs useful as anti-inflammatory/analgesic agents
SE465951B (sv) *	1984-10-23	1991-11-25	Perstorp Ab	Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
SE8605063D0 (sv) *	1986-11-26	1986-11-26	Matti Siren	Derivatives of cyclohexane
SE464059C (sv) *	1988-09-15	1997-06-02	Perstorp Ab	Användning av inositoltrifosfat för framställning av läkemedel
CA2019878A1 (en) *	1989-09-13	1991-03-13	Robert Sabin	Method of treatment of rheumatoid arthritis using phytic acid
SE8904355D0 (sv) *	1989-12-21	1989-12-21	Perstorp Ab	Medicament

1993
- 1993-11-22 SE SE9303854A patent/SE503122C2/sv not_active IP Right Cessation
1994
- 1994-11-18 US US08/640,785 patent/US5866557A/en not_active Expired - Fee Related
- 1994-11-18 AU AU10817/95A patent/AU1081795A/en not_active Abandoned
- 1994-11-18 DK DK95901676T patent/DK0730460T3/da active
- 1994-11-18 JP JP51499395A patent/JP4172045B2/ja not_active Expired - Fee Related
- 1994-11-18 WO PCT/SE1994/001095 patent/WO1995014477A1/en not_active Ceased
- 1994-11-18 DE DE69430813T patent/DE69430813T2/de not_active Expired - Fee Related
- 1994-11-18 EP EP95901676A patent/EP0730460B1/de not_active Expired - Lifetime
- 1994-11-18 ES ES95901676T patent/ES2177620T3/es not_active Expired - Lifetime
- 1994-11-18 AT AT95901676T patent/ATE218871T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0730460A1 (de)	1996-09-11
EP0730460B1 (de)	2002-06-12
US5866557A (en)	1999-02-02
ES2177620T3 (es)	2002-12-16
WO1995014477A1 (en)	1995-06-01
DE69430813T2 (de)	2003-01-30
JP4172045B2 (ja)	2008-10-29
DE69430813D1 (de)	2002-07-18
AU1081795A (en)	1995-06-13
DK0730460T3 (da)	2002-09-23
SE9303854L (sv)	1995-05-23
JPH09505581A (ja)	1997-06-03
SE9303854D0 (sv)	1993-11-22
SE503122C2 (sv)	1996-03-25

Legal Events

Date	Code	Title	Description
2009-08-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69430813D1 (de)	2002-07-18	Verwendung eines inositoltriphosphatesters zur behandlung von entzündungen
Nagase et al.	2005	Treatment of lymphedema with lymphaticovenular anastomoses
Sheldon et al.	1979	Cutaneous mucormycosis: two documented cases of suspected nosocomial cause
Gibbons et al.	1998	Necrotizing fasciitis after tumescent liposuction
Lowe et al.	1982	Double-blind controlled clinical trial of ancrod for ischemic rest pain of the leg
Liebowitz et al.	1960	Anaphylactic reaction to chymotrypsin
Langer et al.	1996	Ultrastructural study of the dermal microvasculature in patients undergoing retrograde intravenous pressure infusions
Kennedy et al.	1966	Amyloidosis presenting as urticaria
Talks et al.	1996	Cryoglobulinaemia masquerading as rheumatoid vasculitis: the retina provides the clue
Glenn	1981	The lymphatic system: Some surgical considerations
HARKINS	1944	The problem of thermal burns: 1944
Markland	1964	Renal artery spasm
Addis	1937	Pathogenesis of eclampsia
Eszenyi-Halasy	1949	Histamine headache
Rupp	1943	Modern Concepts of Refrigeration Anesthesia.
RU2657929C1 (ru)	2018-06-18	Способ коррекции хронических рецидивирующих трещин губ в эксперименте
JPH10511953A (ja)	1998-11-17	成人呼吸窮迫症候群での２，３−アルキルカルボキシ安息香酸の利用
Magee	1967	Clostridium perfringens infection of the biliary tract
Vasave et al.	2021	SINGLE CASE STUDY OF DURVA GHRITA PICHU IN THE MANAGEMENT OF GUDA PARIKARTIKA (FISSURE IN ANO)
Feldman et al.	1951	Acute thrombosis of the femoral artery in an infant
RU2020953C1 (ru)	1994-10-15	Способ лечения тромбоокклюзионных поражений сосудов
SU1210799A1 (ru)	1986-02-15	Способ лечени острого панкреатита
Klassen	1983	Office management of stasis ulcer and stasis dermatitis
BAKER et al.	1964	REGIONAL PERFUSION FOR CONTROL OF ACUTE HEMOLYTIC STREPROCOCCAL GANGRENE: A CASE REPORT
SU950337A1 (ru)	1982-08-15	Способ лечени нагноившихс ран